Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | 600,000 | reported | 21 Jan 2026 | tx 15+2,820,022 |
| G1 Therapeutics, Inc. | 242,286 | reported | 08 Aug 2023 | tx 144+1,093,040−1,030,080 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Jan 2026 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 30 Jan 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 75,000 | 0.00 USD | |
| 30 Jan 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 537,000 | 0.00 USD | deriv |
| 15 Sept 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 5,208 | 3.60 USD | |
| 17 Sept 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 1,000,000 | 0.00 USD | deriv |
| 08 Aug 2023 | EXERCISE | G1 Therapeutics, Inc. | 57,286 | 0.39 USD | |
| 08 Aug 2023 | SALE | G1 Therapeutics, Inc. | 57,286 | 2.00 USD | |
| 08 Aug 2023 | EXERCISE | G1 Therapeutics, Inc. | 2,714 | 0.30 USD | |
| 08 Aug 2023 | SALE | G1 Therapeutics, Inc. | 2,714 | 2.02 USD | anomaly |
| 08 Aug 2023 | EXERCISE | G1 Therapeutics, Inc. | 2,714 | 0.00 USD | deriv |
| 08 Aug 2023 | EXERCISE | G1 Therapeutics, Inc. | 57,286 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 8,929 | 2.10 USD | |
| 16 May 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 16,500 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 11,228 | 1.67 USD | |
| 16 Dec 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 8,424 | 1.50 USD | |
| 18 Oct 2022 | SALE | G1 Therapeutics, Inc. | 15,000 | 11.70 USD | |
| 18 Oct 2022 | EXERCISE | G1 Therapeutics, Inc. | 15,000 | 0.39 USD | |
| 18 Oct 2022 | EXERCISE | G1 Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 20 Sept 2022 | EXERCISE | G1 Therapeutics, Inc. | 20,000 | 0.39 USD | |
| 20 Sept 2022 | SALE | G1 Therapeutics, Inc. | 20,000 | 13.50 USD | |
| 20 Sept 2022 | EXERCISE | G1 Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 4,294 | 2.62 USD | |
| 16 Aug 2022 | SALE | G1 Therapeutics, Inc. | 80,000 | 12.64 USD | anomaly |
| 16 Aug 2022 | EXERCISE | G1 Therapeutics, Inc. | 80,000 | 0.39 USD |